PPARA and metabolic dysfunction-associated steatotic liver disease: In silico docking, strong interactions of key phytochemicals, especially quercetin, luteolin, and β‐sitosterol, with NAFLD‐related targets (PPAR‐α, PPAR‐γ, AMPK, and SREBP‐1c), support the mechanistic basis for its efficacy.